Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × nintedanib × Clear all

NCT01594125 2016-02-12

Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma

Phase 1 Completed

30 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular